Location History:
- Houston, TX (US) (2012)
- Sugar Land, TX (US) (2021 - 2022)
Company Filing History:
3 out of 5,468 
1 out of 37 
1 out of 9 Years Active: 2012-2022
Title: The Innovative Contributions of Ya-Ping Ko
Introduction
Ya-Ping Ko is a prominent inventor based in Sugar Land, TX (US). She has made significant contributions to the field of biotechnology, particularly in the development of therapeutics and vaccines. With a total of three patents to her name, her work focuses on innovative solutions to combat bacterial infections.
Latest Patents
Ya-Ping Ko's latest patents include groundbreaking research on compositions and the use of a fibrinogen binding motif present in extracellular fibrinogen binding proteins (EFB) and clumping factor A (ClfA). One of her patents provides methods and compositions that include vaccines, monoclonal antibodies, and polyclonal antibodies aimed at inhibiting fibrinogen binding and enhancing the immune response against staphylococcus bacteria. Another patent discloses the crystal structure of ClfA in complex with fibrinogen-derived peptides, which is crucial for designing targeted vaccines and therapeutic agents.
Career Highlights
Throughout her career, Ya-Ping Ko has worked with esteemed institutions such as the Texas A&M University System and Technische Universität Braunschweig. Her research has significantly advanced the understanding of bacterial interactions and immune responses, paving the way for new therapeutic strategies.
Collaborations
Ya-Ping Ko has collaborated with notable professionals in her field, including Magnus A. Hook and Emanuel Smeds. These collaborations have further enriched her research and contributed to the development of innovative solutions in biotechnology.
Conclusion
Ya-Ping Ko's contributions to the field of biotechnology through her patents and research collaborations highlight her role as a leading inventor. Her work continues to inspire advancements in therapeutics and vaccines, making a lasting impact on public health.